POA Retrospective Repository



Status:Enrolling by invitation
Conditions:Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:11/2/2017
Start Date:November 30, 2016
End Date:January 1, 2023

Use our guide to learn which trials are right for you!

Caris Molecular Intelligence® and Caris Centers of Excellence for Precision Medicine NetworkTM Retrospective Outcomes-Associated Database

This repository is a multi-center, outcomes study designed to retrospectively collect data on
the demographics, presentation, diagnosis, treatment, cost of associated care, quality of
life, and outcomes of subjects utilizing Caris Molecular Intelligence® (CMI) Services for the
treatment of cancer. Prior to enrolling a subject, the subject's physician will have made the
independent decision whether or not to utilize the drug associations provided by CMI and made
clinical treatment choices as appropriate. Thus, data captured and reported provides a "real
world" perspective on diagnosis, treatment, cost, and outcomes.

This repository is a multi-center, outcomes study designed to retrospectively collect data on
the demographics, presentation, diagnosis, treatment, cost of associated care, quality of
life, and outcomes of subjects utilizing Caris Molecular Intelligence® (CMI) Services for the
treatment of cancer. Prior to enrolling a subject, the subject's physician will have made the
independent decision whether or not to utilize the drug associations provided by CMI and made
clinical treatment choices as appropriate. Thus, data captured and reported provides a "real
world" perspective on diagnosis, treatment, cost, and outcomes.

Patients who have had CMI testing prior to the initial IRB submission date of November 11,
2016 for the respective site would be eligible to have their treatment and treatment response
data entered into the study Database. All entered data would be de-identified. The patient's
CMI biomarker results and treatment response data will be coupled together in order to allow
the investigation of research questions concerning biomarker status and treatment response.

Inclusion Criteria:

- Subject' s age must be greater than or equal to 18 years and must have received CMI
testing prior to the initial protocol IRB submission date of November 11, 2016.

Exclusion Criteria:

- Due to the complexity of state and federal requirements governing the participation of
prisoners in research, prisoners-patients shall not be approached for participation.
We found this trial at
3
sites
Fayetteville, Arkansas 72703
?
mi
from
Fayetteville, AR
Click here to add this to my saved trials
4502 Medical Drive
San Antonio, Texas 78284
(210) 567-7000
University of Texas Health Science Center at San Antonio The University of Texas Health Science...
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
Omaha, Nebraska 68114
?
mi
from
Omaha, NE
Click here to add this to my saved trials